• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9551
Device Problems Fracture (1260); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/05/2024
Event Type  malfunction  
Event Description
It was reported that a stent fracture occurred.The target lesion was located in the left circumflex artery.A 24 x 2.50 promus premier drug eluting stent was advanced for treatment.However, during crossing the lesion, the stent fractured at the first diagonal (dg1).The device was removed, and the procedure was completed with another 2.75 x 24mm promus premier stent.There were no patient complications reported.And the patient was fully recovered.
 
Manufacturer Narrative
The promus premier ous mr 24 x 2.50mm stent delivery system was returned for analysis.Visual and tactile inspection revealed no issues with the shaft, the outer/mid-shaft sections or the inner lumen of the device.Visual and microscopic inspection showed the stent struts were pulled from the mid-section over the distal balloon cone and bumper tip.Microscopic inspection showed no issues with the balloon or bumper tip.The undamaged stent od (outer diameter) was measured within max crimped stent profile measurement.
 
Event Description
It was reported that a stent fracture occurred.The target lesion was located in the left circumflex artery.A 24 x 2.50 promus premier drug eluting stent was advanced for treatment.However, while crossing the lesion, the stent fractured at the first diagonal (dg1).The device was removed, and the procedure was completed with another 2.75 x 24mm promus premier stent.There were no patient complications reported.And the patient was fully recovered.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18769143
MDR Text Key336546569
Report Number2124215-2024-10901
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeTH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9551
Device Catalogue Number9551
Device Lot Number0031624162
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/05/2024
Initial Date FDA Received02/23/2024
Supplement Dates Manufacturer Received04/19/2024
Supplement Dates FDA Received05/02/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/03/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-